Novo Nordisk, Eli Lilly Report GLP-1 Signals of Slowed Biological Aging at ARDD(trial.medpath.com)
49 points by hnburnsy | 26 comments
News article reporting that Novo Nordisk and Eli Lilly presented data at the ARDD conference suggesting GLP-1 drugs may slow biological aging.